Chi V. Dang

Researcher Next ID · RN-024395

Researcher · Biochemistry, Genetics and Molecular Biology

Baltimore, China

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Cancer, Hypoxia, and Metabolism

Epigenetics and DNA Methylation

RNA modifications and cancer

Ubiquitin and proteasome pathways

Cancer-related Molecular Pathways

Drugging the 'undruggable' cancer targets
Nature reviews. Cancer · 2017 · https://doi.org/10.1038/nrc.2017.36
From Krebs to clinic: glutamine metabolism to cancer therapy
Nature reviews. Cancer · 2016 · https://doi.org/10.1038/nrc.2016.71
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers
Cancer Cell · 2015 · https://doi.org/10.1016/j.ccell.2015.09.006
MYC on the Path to Cancer
Cell · 2012 · https://doi.org/10.1016/j.cell.2012.03.003
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Cell · 2011 · https://doi.org/10.1016/j.cell.2011.07.033
Otto Warburg's contributions to current concepts of cancer metabolism
Nature reviews. Cancer · 2011 · https://doi.org/10.1038/nrc3038
Max: functional domains and interaction with c-Myc.
Genes & Development · 1992 · https://doi.org/10.1101/gad.6.1.81
An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
Molecular and Cellular Biology · 1990 · https://doi.org/10.1128/mcb.10.11.5914

No projects listed.